4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-23-015694
EVP, Corp Strategy & Develop sold 345 shares at $190.39 ($65,685)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2023-05-15 | Sale | −345 | $190.39 | $65,685 | 24,026 | D |
| Open-market sales · 345 sh · avg $190.39 · $65,685 | |||||||
Loading xslF345X04/form4.xml…